Defining and conceptualising the commercial determinants of health AB Gilmore, A Fabbri, F Baum, A Bertscher, K Bondy, HJ Chang, ... The Lancet 401 (10383), 1194-1213, 2023 | 412 | 2023 |
Exposing and addressing tobacco industry conduct in low-income and middle-income countries AB Gilmore, G Fooks, J Drope, SA Bialous, RR Jackson The Lancet 385 (9972), 1029-1043, 2015 | 410 | 2015 |
The limits of corporate social responsibility: techniques of neutralization, stakeholder management and political CSR G Fooks, A Gilmore, J Collin, C Holden, K Lee Journal of business ethics 112, 283-299, 2013 | 384 | 2013 |
Globalization and infectious diseases, a review of the linkages L Saker, K Lee, B Cannito, A Gilmore, D Campbell-Lendrum UNDP/World Bank/WHO Special Programme on Tropical Diseases Research, 2004 | 323 | 2004 |
How does the alcohol industry attempt to influence marketing regulations? A systematic review E Savell, G Fooks, AB Gilmore Addiction 111 (1), 18-32, 2016 | 297 | 2016 |
How does the tobacco industry attempt to influence marketing regulations? A systematic review E Savell, AB Gilmore, G Fooks PloS one 9 (2), e87389, 2014 | 284 | 2014 |
The policy dystopia model: an interpretive analysis of tobacco industry political activity S Ulucanlar, GJ Fooks, AB Gilmore PLoS medicine 13 (9), e1002125, 2016 | 255 | 2016 |
Prevalence of smoking in 8 countries of the former Soviet Union: results from the living conditions, lifestyles and health study A Gilmore, J Pomerleau, M McKee, R Rose, CW Haerpfer, D Rotman, ... American journal of public health 94 (12), 2177-2187, 2004 | 245 | 2004 |
Determinants of and inequalities in self-perceived health in Ukraine ABC Gilmore, M McKee, R Rose Social science & medicine 55 (12), 2177-2188, 2002 | 238 | 2002 |
Short term impact of smoke-free legislation in England: retrospective analysis of hospital admissions for myocardial infarction M Sims, R Maxwell, L Bauld, A Gilmore Bmj 340, 2010 | 235 | 2010 |
What is known about tobacco industry efforts to influence tobacco tax? A systematic review of empirical studies KE Smith, E Savell, AB Gilmore Tobacco control 22 (2), e1-e1, 2013 | 215 | 2013 |
Public health, corporations and the new responsibility deal: promoting partnerships with vectors of disease? AB Gilmore, E Savell, J Collin Journal of Public Health 33 (1), 2-4, 2011 | 205 | 2011 |
Tobacco industry influence on science and scientists in Germany T Grüning, AB Gilmore, M McKee American journal of public health 96 (1), 20-32, 2006 | 195 | 2006 |
Corporate social responsibility and access to policy élites: an analysis of tobacco industry documents GJ Fooks, AB Gilmore, KE Smith, J Collin, C Holden, K Lee PLoS medicine 8 (8), e1001076, 2011 | 194 | 2011 |
Trends in the prevalence of smoking in Russia during the transition to a market economy F Perlman, M Bobak, A Gilmore, M McKee Tobacco control 16 (5), 299-305, 2007 | 178 | 2007 |
Understanding tobacco industry pricing strategy and whether it undermines tobacco tax policy: the example of the UK cigarette market AB Gilmore, B Tavakoly, G Taylor, H Reed Addiction 108 (7), 1317-1326, 2013 | 172 | 2013 |
E-cigarettes and equity: a systematic review of differences in awareness and use between sociodemographic groups G Hartwell, S Thomas, M Egan, A Gilmore, M Petticrew Tobacco control 26 (e2), e85-e91, 2017 | 148 | 2017 |
Bringing the commercial determinants of health out of the shadows: a review of how the commercial determinants are represented in conceptual frameworks N Maani, J Collin, S Friel, AB Gilmore, J McCambridge, L Robertson, ... European Journal of Public Health 30 (4), 660-664, 2020 | 135 | 2020 |
Moving East: how the transnational tobacco industry gained entry to the emerging markets of the former Soviet Union—part I: establishing cigarette imports AB Gilmore, M McKee Tobacco control 13 (2), 143-150, 2004 | 134 | 2004 |
Commercial determinants of health: future directions S Friel, J Collin, M Daube, A Depoux, N Freudenberg, AB Gilmore, ... The Lancet 401 (10383), 1229-1240, 2023 | 130 | 2023 |